Grace Therapeutics, Inc. Shareholders' Equity
Grace Therapeutics, Inc. (GRCE) had Shareholders' Equity of $48.21 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $48.21M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $63.90M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $64.89M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $62.82M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $48.21M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $63.90M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $64.89M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $62.82M 10-Q · filed 2026-02-12 |
| 2025-06-30 | $63.55M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $66.61M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $52.14M 10-Q · filed 2026-02-12 |
| 2024-09-30 | $56.13M 10-Q · filed 2026-02-12 |
| 2024-06-30 | $59.36M 10-Q · filed 2026-02-12 |
| 2024-03-31 | $61.74M 10-K · filed 2026-06-18 |
| 2023-12-31 | $64.68M 10-Q · filed 2025-02-13 |
| 2023-09-30 | $66.75M 10-Q · filed 2025-02-13 |
| 2023-06-30 | $64.01M 10-Q · filed 2025-02-13 |
| 2023-03-31 | $67.95M 10-K · filed 2025-06-23 |
| 2022-12-31 | $96.72M 10-Q · filed 2024-02-12 |
| 2022-09-30 | $100.16M 10-Q · filed 2024-02-12 |
| 2022-06-30 | $104.40M 10-Q · filed 2024-02-12 |
| 2022-03-31 | $108.27M 10-K · filed 2024-06-21 |
| 2021-12-31 | $111.06M 10-Q · filed 2023-02-14 |
| 2021-09-30 | $114.20M 10-Q · filed 2023-02-14 |
| 2021-06-30 | $53.46M 10-Q · filed 2023-02-14 |
| 2021-03-31 | $55.66M 10-K · filed 2023-06-23 |
| 2020-12-31 | $25.71M 10-Q · filed 2022-02-14 |
| 2020-09-30 | $8.87M 10-Q · filed 2022-02-14 |
| 2020-06-30 | $11.04M 10-Q · filed 2022-02-14 |
| 2020-03-31 | $12.99M 10-K · filed 2022-06-21 |
| 2019-12-31 | -$4.29M 10-Q · filed 2021-02-09 |
| 2019-09-30 | -$759.00K 10-Q · filed 2021-02-09 |
| 2019-06-30 | $3.27M 10-Q · filed 2021-02-09 |
| 2019-03-31 | $11.04M 10-K · filed 2021-06-22 |
| 2018-03-31 | $7.19M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |